ICP
ABBV icon

Interchange Capital Partners’s AbbVie ABBV Stock Holding History

Interchange Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.15M Sell
15,019
-1,287
-8% -$285K 1% 21
2025
Q4 		$3.73M Buy
16,306
+226
+1% +$51.5K 0.69% 26
2025
Q3 		$3.72M Buy
16,080
+1,305
+9% +$266K 0.73% 24
2025
Q2 		$2.74M Buy
14,775
+66
+0.4% +$12.3K 0.63% 29
2025
Q1 		$3.08M Buy
14,709
+51
+0.3% +$9.91K 0.86% 22
2024
Q4 		$2.6M Sell
14,658
-162
-1% -$29.8K 0.94% 24
2024
Q3 		$2.93M Buy
14,820
+4
+0% +$747 1.03% 20
2024
Q2 		$2.54M Buy
14,816
+13,390
+939% +$2.22M 0.93% 22
2024
Q1 		$261K Buy
1,426
+48
+3% +$8.27K 0.18% 136
2023
Q4 		$214K Sell
1,378
-487
-26% -$71K 0.16% 140
2023
Q3 		$278K Buy
1,865
+137
+8% +$20.1K 0.22% 111
2023
Q2 		$233K Sell
1,728
-11,499
-87% -$1.69M 0.18% 132
2023
Q1 		$2.11M Buy
+13,227
New +$2.02M 1.14% 18
2021
Q4 		– Sell
-13,606
Closed -$1.47M – 151
2021
Q3 		$1.47M Sell
13,606
-67
-0.5% -$7.66K 2.45% 6
2021
Q2 		$1.54M Sell
13,673
-123
-0.9% -$13.9K 2.38% 7
2021
Q1 		$1.5M Sell
13,796
-5
-0% -$535 0.81% 28
2020
Q4 		$1.48M Buy
+13,801
New +$1.33M 0.8% 24

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Interchange Capital Partners's ABBV Position: Q1 2026 in Review

Interchange Capital Partners reduced its AbbVie (ABBV) stake by 7.9% in Q1 2026, selling an estimated $285K and leaving 15,019 shares worth $3.15M. The position accounts for 1% of the portfolio, ranked #21.

Interchange Capital Partners first reported a position in ABBV in Q4 2020 and has held it in 17 quarters since. The position peaked at $3.73M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Interchange Capital Partners held 15,019 shares of AbbVie worth $3.15M as of Q1 2026.
  • Interchange Capital Partners sold 1,287 AbbVie shares in Q1 2026, an estimated $285K.
  • AbbVie made up 1% of Interchange Capital Partners's portfolio in Q1 2026, its #21 holding.
  • Interchange Capital Partners first reported a position in AbbVie in Q4 2020 and has held it in 17 quarters since.
  • Interchange Capital Partners's AbbVie position peaked at $3.73M in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Interchange Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.